Satellos Bioscience Inc. (MSLE)

Satellos Bioscience will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Satellos Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-22.03	-20.63	-11.64
Depreciation & Amortization	0.01	0.02	0.01
Share-Based Compensation	-	1.64	1.59
Other Operating Activities	0.46	0.73	1.56
Operating Cash Flow	-21.55	-18.25	-8.49
Capital Expenditures	-0.01	-0	-0.01
Change in Investments	-	4.66	-12.83
Other Investing Activities	-15.79	-	0
Investing Cash Flow	-15.8	4.66	-12.85
Share Issuance / Repurchase	-	37.57	37.22
Debt Issued / Paid	-	-	-0.28
Financing Cash Flow	39.48	37.57	36.94
Net Cash Flow	1.94	23.39	14.75
Free Cash Flow	-21.56	-18.26	-8.5

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).